Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 70, 2006 - Issue 2
Journal homepage
258
Views
33
CrossRef citations to date
0
Altmetric
Original Articles

Isomer-Specific Anti-Obese and Hypolipidemic Properties of Conjugated Linoleic Acid in Obese OLETF Rats

Yu-Ming WANGDepartment of Applied Biological Sciences, Saga University
,
Koji NAGAODepartment of Applied Biological Sciences, Saga University
,
Nao INOUEDepartment of Applied Biological Sciences, Saga University
,
Yoko UJINODepartment of Applied Biological Sciences, Saga University
,
Yuji SHIMADADepartment of Biochemistry, Osaka Municipal Technical Research Institute
,
Toshihiro NAGAODepartment of Biochemistry, Osaka Municipal Technical Research Institute
,
Toshio IWATAResearch Laboratory, The Nisshin OilliO Group, Ltd.
,
Takeshi KAMEGAIResearch Laboratory, The Nisshin OilliO Group, Ltd.
,
Yoshie YAMAUCHI-SATOResearch Laboratory, The Nisshin OilliO Group, Ltd.
&
Teruyoshi YANAGITADepartment of Applied Biological Sciences, Saga University
 show all
Pages 355-362 | Received 02 Jun 2005, Accepted 22 Oct 2005, Published online: 22 May 2014

  • 1) Kissebah, A. H., and Krakower, G. R., Regional adiposity and morbidity. Physiol. Rev., 74, 761–811 (1994).
  • 2) Must, A., Spadano, J., Coakley, E. H., Field, A. E., Colditz, G., and Detz, W. H., The disease burden associated with overweight and obesity. JAMA, 282, 1523–1529 (1999).
  • 3) Adler, A., Obesity and target organ damage: diabetes. Int. J. Obes. Relat. Metab. Disord., 26, S11–S14 (2002).
  • 4) Fiegal, K. M., Carroll, M. D., Ogden, C. L., and Johnson, C. L., Prevalence and trends in obesity among U.S. adults 1999–2000. JAMA, 288, 1723–1727 (2002).
  • 5) Pi-Sunyer, F. X., The medical risks of obesity. Obes. Surg., 12, S6–S11 (2002).
  • 6) Cunnane, S. C., McAdoo, K. R., and Horrobin, D. F., N-3 essential fatty acids decrease weight gain in genetically obese mice. Br. J. Nutr., 56, 87–95 (1986).
  • 7) Belzung, F., Raclot, T., and Groscolas, R., Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am. J. Physiol., 264, R1111–R1118 (1993).
  • 8) Hill, J. O., Peters, J. C., Lin, D., Yakubu, F., Greene, H., and Swift, L., Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int. J. Obes. Relat. Metab. Disord., 17, 223–226 (1993).
  • 9) Nakatani, T., Kim, H. J., Kaburagi, Y., Yasuda, K., and Ezaki, O., A low fish oil inhibits SREBP-1 proteolytic cascade, while a high-fish-oil feeding decreases SREBP-1 mRNA in mice liver: relationship to anti-obesity. J. Lipid Res., 44, 369–379 (2003).
  • 10) Ha, Y. L., Grimm, N. K., and Pariza, M. W., Newly recognized anticarcinogenic fatty acids: identification and quantification in natural and processed cheeses. J. Agric. Food Chem., 37, 75–81 (1989).
  • 11) Chin, S. F., Liu, W., Storkson, J. M., Ha, Y. L., and Pariza, M. W., Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J. Food Comp. Anal., 5, 185–197 (1992).
  • 12) Ip, C., Singh, M., Thomson, H. J., and Scimeca, J. A., Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res., 54, 1212–1215 (1994).
  • 13) Ip, C., Scimeca, J. A., and Thompson, H. J., Conjugated linoleic acid, a powerful anticarcinogen from animal fat sources. Cancer, 74, 1050–1054 (1994).
  • 14) Lee, K. N., Kritchevsky, D., and Pariza, M. W., Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis, 108, 19–25 (1994).
  • 15) Park, Y., Albright, K. J., Storkson, J. M., Liu, W., Cook, M. E., and Pariza, M. W., Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids, 34, 243–248 (1999).
  • 16) Delany, J. P., Blohm, F., Truett, A. A., Scimeca, J. A., and West, D. B., Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am. J. Physiol., 276, R1172–R1179 (1999).
  • 17) Thom, E., Wadstein, J., and Gudmundsen, O., Conjugated linoleic acid reduces body fat in healthy exercising humans. J. Int. Med. Res., 29, 392–396 (2001).
  • 18) Smedman, A., and Vessby, B., Conjugated linoleic acid supplementation in human metabolic effects. Lipids, 36, 773–781 (2001).
  • 19) Eulitz, K., Yurawecz, M. P., Sehat, N., Fritsche, J., Roach, J. A. G., Mossoba, M. M., Kramer, J. K., Adlof, R. O., and Ku, Y., Preparation, separation, and confirmation of the eight geometrical cis/trans conjugated linoleic acid isomers 8,10- through 11,13-18:2. Lipids, 34, 873–877 (1999).
  • 20) Bauman, D. E., Barbano, D. M., Dwyer, D. A., and Griinari, J. M., Production of butter with enhanced conjugated linoleic acid for use in biomedical studies with animal models. J. Dairy Sci., 83, 2422–2425 (2000).
  • 21) Park, Y., Albright, K. J., Storkson, J. M., Liu, W., and Pariza, M. W., Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids, 34, 235–241 (1999).
  • 22) Choi, Y., Kim, Y. C., Han, Y. B., Park, Y., Pariza, M. W., and Ntambi, J. M., The trans-10,cis-12 isomer of conjugated linoleic acid downregulates stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes. J. Nutr., 130, 1920–1924 (2000).
  • 23) Choi, Y., Park, Y., Pariza, M. W., and Ntambi, J. M., Regulation of stearoyl-CoA desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells. Biochem. Biophys. Res. Commun., 284, 689–693 (2001).
  • 24) Ryder, J. W., Portocarrero, C. P., Song, X. M., Cui, L., Yu, M., Combatsiaris, T., Galuska, D., Bauman, D. E., Barbano, D. M., Charron, M. J., Zierath, J. R., and Houseknecht, K. L., Isomer-specific antidiabetic properties of conjugated linoleic acid: improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes, 50, 1149–1157 (2001).
  • 25) Yotsumoto, H., Hara, E., Naka, S., Adlof, R. O., Emken, E. A., and Yanagita, T., 10trans, 12cis-Linoleic acid reduces apolipoprotein B secretion in HepG2 cells. Food Res. Int., 31, 403–409 (1999).
  • 26) Kawano, K., Hirashima, T., Mori, S., Saitoh, Y., Kurosumi, M., and Natori, T., Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes, 41, 1422–1428 (1992).
  • 27) Kawano, K., Hirashima, T., Mori, S., and Natori, T., OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res. Clin. Pract., 24, S317–S320 (1994).
  • 28) Takiguchi, S., Takata, Y., Funakoshi, A., Miyasaka, K., Kataoka, K., Fujimura, Y., Goto, T., and Kono, A., Disrupted cholecystokinin-type A receptor (CCKAR) gene in OLETF rats. Gene, 197, 169–175 (1997).
  • 29) Moran, T. H., Katz, L. F., Plata-Salaman, C. R., and Schwartz, G. J., Disordered food intake and obesity in rats lacking cholecystokinin A (CCKA) receptors. Am. J. Physiol., 274, R618–R625 (1998).
  • 30) Nagao, T., Yamauchi-Sato, Y., Shimada, Y., Iwata, T., Nagao, K., Yanagita, T., Adachi, S., and Sugihara, A., Highly purification of conjugated linoleic acid isomers through a process including lipase-catalyzed selective esterification. Biosci. Biotechnol. Biochem., 67, 1429–1433 (2003).
  • 31) Rahman, S. M., Wang, Y. M., Han, S. Y., Cha, J. Y., Fukuda, N., Yotsumoto, H., and Yanagita, T., Effects of short-term administration of conjugated linoleic acid on lipid metabolism in white and brown adipose tissues of starved/refed Otsuka Long-Evans Tokushima Fatty rats. Food Res. Int., 34, 515–520 (2001).
  • 32) Nagao, K., Wang, Y. M., Inoue, N., Han, S. Y., Buang, Y., Noda, T., Kouda, N., Okamatsu, H., and Yanagita, T., The 10trans, 12cis isomer of conjugated linoleic acid promotes energy metabolism in OLETF rats. Nutrition, 19, 652–656 (2003).
  • 33) Folch, J., Lee, M., and Sloane-Stanley, G. H., A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497–509 (1957).
  • 34) Fletcher, M. J., A colorimetric method for estimation of serum triglycerides. Clin. Chim. Acta, 22, 393–397 (1968).
  • 35) Sperry, W. M., and Webb, M., A revision of the Schoenheimer-Sperry method for cholesterol determination. J. Biol. Biochem., 187, 97–106 (1950).
  • 36) Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265–275 (1951).
  • 37) Kelley, D. S., and Kletzien, R. F., Ethanol modulation of the hormonal and nutritional regulation of glucose 6-phosphate dehydrogenase activity in primary cultures of rat hepatocytes. Biochem. J., 217, 543–549 (1984).
  • 38) Markwell, M. A. K., McGroarty, E. J., Bieber, L. L., and Tolbert, N. E., The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. J. Biol. Chem., 248, 3433–3440 (1973).
  • 39) Duncan, D. B., Multiple range and multiple F tests. Biometrics, 11, 1–42 (1955).
  • 40) Clement, L., Pirier, H., Niot, I., Bocher, V., Guerre-Millo, M., Krief, S., Staels, B., and Besnard, P., Dietary trans-10,cis-12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J. Lipid Res., 43, 1400–1409 (2002).
  • 41) Takahashi, Y., Kushiro, M., Shinohara, K., and Ide, T., Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis and oxidation in mice fed conjugated linoleic acid. Biochim. Biophys. Acta, 1631, 265–273 (2003).
  • 42) Rahman, S. M., Wang, Y. M., Yotsumoto, H., Cha, J. Y., Han, S. Y., Inoue, S., and Yanagita, T., Effects of conjugated linoleic acid on serum leptin concentration, body-fat accumulation, and beta-oxidation of fatty acid in OLETF rats. Nutrition, 17, 385–390 (2001).
  • 43) Wang, Y. M., Rahman, S. M., Nagao, K., Arao, K., Inoue, N., and Yanagita, T., Comparison of the effects of triacylglycerol-CLA and free fatty acid-CLA on hepatic lipid metabolism in OLETF obese rats. J. Oleo Sci., 52, 121–128 (2003).
  • 44) Wang, Y. M., Rahman, S. M., Nagao, K., Han, S. Y., Buang, Y., Cha, J. Y., and Yanagita, T., Conjugated linoleic acid reduces hepatic microsomal triacylglycerol transfer protein activity and hepatic triacylglycerol mass in obese rats. J. Oleo Sci., 52, 129–134 (2003).
  • 45) Berven, G., Bye, A., Hals, O., Blankson, H., Fagertun, H., Thom, E., Wadstein, J., and Gudmundsen, O., Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur. J. Lipid Sci. Technol., 102, 455–462 (2000).
  • 46) Kreider, R. B., Ferreira, M. P., Greenwood, M., Wilson, M., and Almada, A. L., Effect of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J. Strength Cond. Res., 16, 325–334 (2002).
  • 47) Tsuboyama-Kasaoka, N., Miyazaki, H., Kasaoka, S., and Ezaki, O., Increasing the amount of fat in a conjugated linoleic acid-supplemented diet reduces lipodystrophy in mice. J. Nutr., 133, 1793–1799 (2003).
  • 48) Schoonjans, K., Staels, B., and Auwerx, J., Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrate and fatty acids on gene expression. J. Lipid Res., 37, 907–925 (1996).
  • 49) Belury, M. A., Moya, C. S. Y., Liu, K. L., and Vanden, H. J. P., Dietary conjugated linoleic acid induces peroxisome-specific enzyme accumulation and ornithine decarboxylase activity in mouse liver. J. Nutr. Biochem., 8, 579–584 (1997).
  • 50) Peters, J. M., Park, Y., Gonzalez, F. J., and Pariza, M. W., Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha-null mice. Biochim. Biophys. Acta, 1553, 233–242 (2001).
  • 51) Horton, J. D., Goldstein, J. L., and Brown, M. S., SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest., 109, 1125–1131 (2002).
  • 52) Kang, K., and Pariza, M. W., trans-10,cis-12-Conjugated linoleic acid reduces leptin secretion from 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun., 287, 377–382 (2001).
  • 53) Masuo, K., Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin. Curr. Hypertens. Rep., 4, 112–118 (2002).
  • 54) Zimmet, P., Boyko, E. J., Collier, G. R., and de Courten, M., Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann. NY Acad. Sci., 892, 25–44 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.